In Vitro Characterization of Cannabidiol As a Possible Adjuvant for Long-Lasting Local Anesthesia.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 42268648.
- Also identified by DOI 10.1213/ANE.0000000000008095.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cannabidiol (CBD) inhibits voltage-gated sodium channels (Nav). CBD is highly lipophilic and exhibits slow binding kinetics on Navs, a property that may enable CBD to enhance and prolong regional anesthesia. Here we explored the effects of CBD on lidocaine-induced Nav-inhibition and neurotoxicity. Patch clamp recordings were performed on tetrodotoxin (TTX)-sensitive Navs and the TTX-resistant Nav1.8 in ND7/23 cells or murine dorsal root ganglion neurons (DRG). Cytotoxicity was analyzed using flow cytometry. CBD induced a potent tonic inhibition of sodium currents with slow onset and offset kinetics. Nav1.8 exhibited a higher sensitivity to tonic block (IC50 1.4 µM) as compared to TTX-sensitive sodium channels (IC50 2.9 µM). Similar to local anesthetics, CBD also induced a shift of the steady-state inactivation and a modest use-dependent block at 10 Hz. In contrast to local anesthetics, inhibition of Navs by CBD is pH-independent. The co-application of CBD and lidocaine resulted in an additive tonic block of sodium currents in ND7/23 cells, but not in DRG neurons. While only high concentrations of CBD induced cytotoxicity, it potentiated lidocaine-induced cytotoxicity. CBD demonstrates promising characteristics as a long-lasting local anesthetic, or as an adjunct to local anesthetics used for regional or topical anesthesia.